EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules

Robert C Wells, Padma Akkapeddi, Darren Chan, David Joy, Arash Moshkforoush, Roni Chau, Johann Chow, Gerald Maxwell Cherf, Ellen Y T Chien, Allisa Clemens, Michelle E Pizzo, Ahlam N Qerqez und 25 weitere

Cell Reports · 2025-08 · 44 (8) · 116038

DOI: 10.1016/j.celrep.2025.116038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-08. Verfasst von Robert C Wells und 36 weiteren Autor:innen. Beteiligte Einrichtung: Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: wells@dnli.com. Hauptthemen laut MEDLINE: Receptors, Transferrin, Brain. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting proteins highly expressed at the blood-brain barrier, including transferrin receptor (TfR) and CD98hc, is a transformative approach enabling more effective brain delivery of biotherapeutics to treat neurological diseases. TfR-mediated delivery promotes rapid, high brain uptake, while CD98hc-mediated delivery is slower with more prolonged exposure. Here, we engineer a human immunoglobulin G1 (huIgG) Fc domain to bind both TfR and CD98hc, creating a dual transport vehicle (TV) platform that drives distinct brain delivery properties. Dual TVs achieve significantly higher brain concentrations than TVs targeting either TfR or CD98hc alone. Modulation of TfR and CD98hc affinities shifts dual TV brain exposure kinetics and biodistribution. Stronger TfR affinity drives faster brain uptake and catabolism, while stronger CD98hc affinity yields higher, more sustained concentrations, likely due to CD98hc affinity-dependent reduction in TfR-mediated neuronal internalization. This dual-targeting strategy leverages the complementary properties of TfR- and CD98hc-mediated brain exposure to increase the optionality for brain delivery of biotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, TransferrinBrainHumansAnimalsBlood-Brain BarrierMiceImmunoglobulin GTissue DistributionMale

Stichwörter der Autor:innen

CD98hcCP: Molecular biologyCP: NeuroscienceTransportVehicleantibodybiodistributionbispecificdrug delivery to the brainpharmacokineticstransferrin receptor

Substanzen

Receptors, TransferrinImmunoglobulin G

Autor:innen und Institutionen

  • Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: wells@dnli.com.
  • Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA.
  • Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.
  • Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: zuchero@dnli.com.
  • Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. Electronic address: chew@dnli.com.

Zitieren

APA

Wells, R. C., Akkapeddi, P., Chan, D., Joy, D., Moshkforoush, A., Chau, R., Chow, J., Cherf, G. M., Chien, E. Y. T., Clemens, A., Pizzo, M. E., Qerqez, A. N., Tran, T., Becerra, I., Dugas, J. C., Duque, J., Earr, T. K., Huynh, D., Kim, D. J., …, & Chew, K. S. (2025). Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules. Cell Reports, 44(8), 116038. https://doi.org/10.1016/j.celrep.2025.116038

Vancouver

Wells RC, Akkapeddi P, Chan D, Joy D, Moshkforoush A, Chau R, et al. Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules. Cell Reports. 2025;44(8):116038. doi:10.1016/j.celrep.2025.116038

BibTeX
@article{Wells2025,
  author = {Wells, Robert C and Akkapeddi, Padma and Chan, Darren and Joy, David and Moshkforoush, Arash and Chau, Roni and Chow, Johann and Cherf, Gerald Maxwell and Chien, Ellen Y T and Clemens, Allisa and Pizzo, Michelle E and Qerqez, Ahlam N and Tran, Tiffany and Becerra, Isabel and Dugas, Jason C and Duque, Joseph and Earr, Timothy K and Huynh, David and Kim, Do Jin and Wing-Sze Leung, Amy and Liang, Eric and Nguyen, Hoang N and Robles-Colmenares, Yaneth and Kane, Holly and Roche, Elysia and Sacayon, Patricia and Xa, Kaitlin and Solanoy, Hilda and Dennis, Mark S and Lewcock, Joseph W and Watts, Ryan J and Kariolis, Mihalis S and Thorne, Robert G and Koth, Christopher M and Calvert, Meredith E K and Yu Zuchero, Y Joy and Chew, Kylie S},
  title = {Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {8},
  pages = {116038},
  doi = {10.1016/j.celrep.2025.116038}
}
Kostenlos starten →